Transcription of Public Assessment Report - GOV.UK
{{id}} {{{paragraph}}}
Public Assessment Report Decentralised Procedure MITOMYCIN 40 MG POWDER FOR SOLUTION FOR INJECTION/INFUSION (mitomycin) Procedure No: UK/H/5178/001/DC UK Licence No: PL 04569/1552 Generics (UK) Limited trading as MylanPAR Mitomycin 40 mg powder for solution for injection/infusion UK/H/5178/001/DC 2 LAY SUMMARY Mitomycin 40 mg powder for solution for injection/infusion (mitomycin) This is a summary of the Public Assessment Report (PAR) for Mitomycin 40 mg powder for solution for injection/infusion (PL 04569/1552; UK/H/5178/001/DC). It explains how Mitomycin 40 mg powder for solution for injection/infusion was assessed and its authorisation recommended as well as its conditions of use.
Public Assessment Report Decentralised Procedure MITOMYCIN 40 MG POWDER FOR SOLUTION FOR INJECTION/INFUSION (mitomycin) Procedure No: UK/H/5178/001/DC
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
TO ICH E11: CLINICAL INVESTIGATION, GUIDELINE, TO ICH E11: CLINICAL INVESTIGATION OF MEDICINAL, Clinical investigation of medicinal products for, Clinical investigation of medicinal products, Clinical development of fixed, Clinical development of fixed combination medicinal, Good Clinical Practice, Section 1: Legislation, Clinical